>104K_THEPA 104 KD MICRONEME-RHOPTRY ANTIGEN
MKFLILLFNILCLFPVLAADNHGVGPQGASGVDPITFDINSNQTGPAFLTAVEMAGVKYLQVQHGSNVNI
HRLVEGNVVIWENASTPLYTGAIVTNNDGPYMAYVEVLGDPNLQFFIKSGDAWVTLSEHEYLAKLQEIRQ
AVHIESVFSLNMAFQLENNKYEVETHAKNGANMVTFIPRNGHICKMVYHKNVRIYKATGNDTVTSVVGFF
RGLRLLLINVFSIDDNGMMSNRYFQHVDDKYVPISQKNYETGIVKLKDYKHAYHPVDLDIKDIDYTMFHL
ADATYHEPCFKIIPNTGFCITKLFDGDQVLYESFNPLIHCINEVHIYDRNNGSIICLHLNYSPPSYKAYL
VLKDTGWEATTHPLLEEKIEELQDQRACELDVNFISDKDLYVAALTNADLNYTMVTPRPHRDVIRVSDGS
EVLWYYEGLDNFLVCAWIYVSDGVASLVHLRIKDRIPANNDIYVLKGDLYWTRITKIQFTQEIKRLVKKS
KKKLAPITEEDSDKHDEPPEGPGASGLPPKAPGDKEGSEGHKGPSKGSDSSKEGKKPGSGKKPGPAREHK
PSKIPTLSKKPSGPKDPKHPRDPKEPRKSKSPRTASPTRRPSPKLPQLSKLPKSTSPRSPPPPTRPSSPE
RPEGTKIIKTSKPPSPKPPFDPSFKEKFYDDYSKAASRSKETKTTVVLDESFESILKETLPETPGTPFTT
PRPVPPKRPRTPESPFEPPKDPDSPSTSPSEFFTPPESKRTRFHETPADTPLPDVTAELFKEPDVTAETK
SPDEAMKRPRSPSEYEDTSPGDYPSLPMKRHRLERLRLTTTEMETDPGRMAKDASGKPVKLKRSKSFDDL
TTVELAPEPKASRIVVDDEGTEADDEETHPPEERQKTEVRRRRPPKKPSKSPRPSKPKKPKKPDSAYIPS
ILAILVVSLIVGIL

>10KD_VIGUN 10 KD PROTEIN PRECURSOR (CLONE: PSAS10)
MEKKSIAGLCFLFLVLFVAQEVVVQSEAKTCENLVDTYRGPCFTTGSCDDHCKNKEHLLSGRCRDDVRCW
CTRNC

>10KS_HUMAN CLARA CELLS 10 KD SECRETORY PROTEIN PRECURSOR (CC10)
MKLAVTLTLVTLALCCSSASAEICPSFQRVIETLLMDTPSSYEAAMELFSPDQDMREAGAQLKKLVDTLP
QKPRESIIKLMEKIAQSSLCN

>10KS_RAT CLARA CELLS 10 KD SECRETORY PROTEIN PRECURSOR (CC10) (PCB-BINDING PROTEIN)
MKIAITITVLMLSICCSSASSDICPGFLQVLEALLLGSESNYEAALKPFNPASDLQNAGTQLKRLVDTLP
QETRINIVKLTEKILTSPLCEQDLRV

>110K_PLAKN 110 KD ANTIGEN (PK110) (FRAGMENT)
FNSNMLRGSVCEEDVSLMTSIDNMIEEIDFYEKEIYKGSHSGGVIKGMDYDLEDDENDEDEMTEQMVEEV
ADHITQDMIDEVAHHVLDNITHDMAHMEEIVHGLSGDVTQIKEIVQKVNVAVEKVKHIVETEETQKTVEP
EQIEETQNTVEPEQTEETQKTVEPEQTEETQNTVEPEQIEETQKTVEPEQTEEAQKTVEPEQTEETQKTV
EPEQTEETQKTVEPEQTEETQKTVEPEQTEETQKTVEPEQTEETQKTVEPEQTEETQKTVEPEQTEETQN
TVEPEPTQETQNTVEP

>11KD_ADE02 11 KD CORE PROTEIN PRECURSOR (LATE L2 MU CORE PROTEIN) (PROTEIN X)
ALTCRLRFPVPGFRGRMHRRRGMAGHGLTGGMRRAHHRRRRASHRRMRGGILPLLIPLIAAAIGAVPGIA
SVALQAQRH

>11S3_HELAN 11S GLOBULIN SEED STORAGE PROTEIN G3 PRECURSOR (HELIANTHININ G3)
MASKATLLLAFTLLFATCIARHQQRQQQQNQCQLQNIEALEPIEVIQAEAGVTEIWDAYDQQFQCAWSIL
FDTGFNLVAFSCLPTSTPLFWPSSREGVILPGCRRTYEYSQEQQFSGEGGRRGGGEGTFRTVIRKLENLK
EGDVVAIPTGTAHWLHNDGNTELVVVFLDTQNHENQLDENQRRFFLAGNPQAQAQSQQQQQRQPRQQSPQ
RQRQRQRQGQGQNAGNIFNGFTPELIAQSFNVDQETAQKLQGQNDQRGHIVNVGQDLQIVRPPQDRRSPR
QQQEQATSPRQQQEQQQGRRGGWSNGVEETICSMKFKVNIDNPSQADFVNPQAGSIANLNSFKFPILEHL
RLSVERGELRPNAIQSPHWTINAHNLLYVTEGALRVQIVDNQGNSVFDNELREGQVVVIPQNFAVIKRAN
EQGSRWVSFKTNDNAMIANLAGRVSASAASPLTLWANRYQLSREEAQQLKFSQRETVLFAPSFSRGQGIR
ASR

>11SB_CUCMA 11S GLOBULIN BETA SUBUNIT PRECURSOR
MARSSLFTFLCLAVFINGCLSQIEQQSPWEFQGSEVWQQHRYQSPRACRLENLRAQDPVRRAEAEAIFTE
VWDQDNDEFQCAGVNMIRHTIRPKGLLLPGFSNAPKLIFVAQGFGIRGIAIPGCAETYQTDLRRSQSAGS
AFKDQHQKIRPFREGDLLVVPAGVSHWMYNRGQSDLVLIVFADTRNVANQIDPYLRKFYLAGRPEQVERG
VEEWERSSRKGSSGEKSGNIFSGFADEFLEEAFQIDGGLVRKLKGEDDERDRIVQVDEDFEVLLPEKDEE
ERSRGRYIESESESENGLEETICTLRLKQNIGRSVRADVFNPRGGRISTANYHTLPILRQVRLSAERGVL
YSNAMVAPHYTVNSHSVMYATRGNARVQVVDNFGQSVFDGEVREGQVLMIPQNFVVIKRASDRGFEWIAF
KTNDNAITNLLAGRVSQMRMLPLGVLSNMYRISREEAQRLKYGQQEMRVLSPGRSQGRRE

>120K_RICRI 120 KD SURFACE-EXPOSED PROTEIN
MVIQSANATGQVNFRHIVDVGADGTTAFKTAASKVTITQDSNFGNTDFGNLAAQIKVPNAITLTGNFTGD
ASNPGNTAGVITFDANGTLESASADANVAVTNNITAIEASGAGVVQLSGTHAAELRLGNAGSIFKLADGT
VINGKVNQTALVGGALAAGTITLDGSATITGDIGNAGGAAALQRITLANDAKKTLTLGGANIIGAGGGTI
DLQANGGTIKLTSTQNNIVVDFDLAIATDQTGVVDASSLTNAQTLTINGKIGTIGANNKTLGQFNIGSSK
TVLSNGNVAINELVIGNDGAVQFAHDTYLITRTTNAAGQGKIIFNPVVNNGTTLAAGTNLGSATNPLAEI
NFGSKGVNVDTVLNVGEGVNLYATNITTTDANVGSFVFNAGGTNIVSGTVGGQQGNKFNTVALENGTTVK
FLGNATFNGNTTIAANSTLQIGGNYTADCVASADGTGIVEFVNTGPITVTLNKEAAPVNALKQITVSGPG
NVVINEIGNAGNHHGAVTDTIAFENSSLGAVVFLPRGIPFNDAGNTMPLTIKSTVGNKTAKGFDVPSVVV
LGVDSVIADGQVIVDQNNIVGLGLGSDNGIIVNATTLYAGISTLNNNQGTVTLSGGVPNTPGTVYGLGTG
IGASKFKQVTFTTDYNNLGNIIATNATINDGVTVTTGGIAGIGFDGKITLGSVNGNGNVRFADGILSNST
SMIGTTKANNGTVTYLGNAFVGNIGDSDTPVASVRFTGSDSGAGLQGNIYSQVIDFGTYNLGIVNSNIIL
GGGTTAINGKIDLVTNTLTFASGTSTWGNNTSIETTLTLANGNIGHIVILEGAQVNTTTTGTTTIKVQDN
ANANFSGTQTYTLIQGGARFNGTLGSPNFAVTGSNRFVNYSLIRAANQDYVITRTNNAENVVTNDIANSP
FGGAPGVDQNVTTFVNATNTAAYNNLLLAKNSANSANFVGAIVTDTSAAITNVQLDLAKDIQAQLGNRLG
ALRYLGTPETAEMADLKLEHIGSVAAGDEAIDNVAYGIWAKPFYTDAHQSKKGGLAGYKAKTTGVVIGLD
TLANDNLMIGAAIGITKTDIKHQDYKKGDKTDVNGFSFSLYGAQQLVKNFFAQGSAIFSLNQVKNKSQRY
FFDANGNMSKQIAAGHYDNMTFGGNLTVGYDYNAMQGVLVTPMAGLSYLKSSDENYKETGTTVANKQVNS
KFSDRTDLIVGAKVAGSTMNRTDLAVYPEVHAFVVHKVTGRLSKTQSVLDGQVTPCINQPDRTTKTSYNL
GLSASIRSDAKMEYGIGYDAQISSKYTAHQGTLKVRVNF

>128U_DROME GTP-BINDING PROTEIN 128UP
MITILEKISAIESEMARTQKNKATSAHLGLLKANVAKLRRELISPKGGGGGTGEAGFEVAKTGDARVGFV
GFPSVGKSTLLSNLAGVYSEVAAYEFTTLTTVPGCIKYKGAKIQLLDLPGIIEGAKDGKGRGRQVIAVAR
TCNLIFMVLDCLKPLGHKKLLEHELEGFGIRLNKKPPNIYYKRKDKGGINLNSMVPQSELDTDLVKTILS
EYKIHNADITLRYDATSDDLIDVIEGNRIYIPCIYLLNKIDQISIEELDVIYKIPHCVPISAHHHWNFDD
LLELMWEYLRLQRIYTKPKGQLPDYNSPVVLHNERTSIEDFCNKLHRSIAKEFKYALVWGSSVKHQPQKV
GIEHVLNDEDVVQIVKKV

>12AH_CLOS4 12-ALPHA-HYDROXYSTEROID DEHYDROGENASE (EC 1.1.1.176) (FRAGMENT)
MIFDGKVAIITGGGKAKSIGYGIAVAYAK

>12KD_MYCLE 12 KD PROTEIN
MNDIIALKFHISLNATTWIGRIGMVILPLLVYFITYRWCIGLQRSDRAVLEHGIETGIIKRLPHGAYIEL
HQPLGPVDDHGHPIPLEYQGTAVPKRMNKLGSAGSPSSGSFLFADPVSEDAALREATHVAEQRALTALRE
HQDSIASSPNGERGKH

>12S1_ARATH 12S SEED STORAGE PROTEIN
MARVSSLLSFCLTLLILFHGYAAQQGQQGQQFPNECQLDQLNALEPSHVLKSEAGRIEVWDHHAPQLRCS
GVSFARYIIESKGLYLPSFFNTAKLSFVAKGRGLMGKVIPGCAETFQDSSEFQPRFEGQGQSQRFRDMHQ
KVEHIRSGDTIATTPGVAQWFYNDGQQPLVIVSVFDLASHQNQLDRNPRPFYLAGNNPQGQVWLQGREQQ
PQKNIFNGFGPEVIAQALKIDLQTAQQLQNQDDNRGNIVRVQGPFGVIRPPLRGQRPQEEEEEEGRHGRH
GNGLEETICSARCTDNLDDPSRADVYKPQLGYISTLNSYDLPILRFIRLSALRGSIRQNAMVLPQWNANA
NAILYETDGEAQIQIVNDNGNRVFDGQVSQGQLIAVPQGFSVVKRATSNRFQWVEFKTNANAQINTLAGR
TSVLRGLPLEVITNGFQISPEEARRVKFNTLETTLTHSSGPASYGRPRVAAA

>12S2_ARATH 12S SEED STORAGE PROTEIN
MGRVSSIISFSLTLLILFNGYTAQQWPNECQLDQLNALEPSQIIKSEGGRIEVWDHHAPQLRCSGFAFER
FVIEPQGLFLPTFLNAGKLTFVVHGRGLMGRVIPGCAETFMESPVFGEGQGQGQSQGFRDMHQKVEHLRC
GDTIATPSGVAQWFYNNGNEPLILVAAADLASNQNQLDRNLRPFLIAGNNPQGQEWLQGRKQQKQNNIFN
GFAPEILAQAFKINVETAQQLQNQQDNRGNIVKVNGPFGVIRPPLRRGEGGQQPHEIANGLEETLCTMRC
TENLDDPSDADVYKPSLGYISTLNSYNLPILRLLRLSALRGSIRKNAMVLPQWNVNANAALYVTNGKAHI
QMVNDNGERVFDQEISSGQLLVVPQGFSVMKHRIGEQFEWIEFKTNENAQVNTLAGRTSVMRGLPLEVIT
NGYQISPEEAKRVKFSTIETTLTHSSPMSYGRPRA

>1433_DROME 14-3-3-LIKE PROTEIN
MSTVDKEELVQKAKLAEQSERYDDMAQAMKSVTETGVELSNEERNLLSVAYKNVVGARRSSWRVISSIEQ
KTEASARKQQLAREYRERVEKELREICYEVLGLLDKYLIPKASNPESKVFYLKMKGDYYRYLAEVATGDA
RNTVVDDSQTAYQDAFDISKGKMQPTHPIRLGLALNFSVFYYEILNSPDKACQLAKQAFDDAIAELDTLN
EDSYKDSTLIMQLLRDNLTLWTSDTQGDEAEPQEGGDN

>1433_HORVU 14-3-3-LIKE PROTEIN
MSTAEATREENVYMAKLAEQAERYEEMVEFMEKVAKTADVGELTVEERNLLSVAYKNVIGARRASWRIIS
SIEQKEESRGNEAYVASIKEYRTRIETELSKICDGILKLLDSHLVPSATAAESKVFYLKMKGDYHRYLAE
FKAGAERKEAAENTLVAYKSAQDIALADLPTTHPIRLGLALNFSVFYYEILNSPDRACNLAKQAFDEAIA
ELDSLGEESYKDSTLIMQLLRDNLTLWTSDNAEEGGDEIKEAASKPEGEGHS

>1433_MAIZE 14-3-3-LIKE PROTEIN (FRAGMENT)
ILNSPDRACNLAKQAFDEAISELDSLGEESYKDSTLIMQLLXDNLTLWTSDTNEDGGDEIK

>1433_OENHO 14-3-3-LIKE PROTEIN
MATAPSPREENVYLAKLAEQAERYEEMVEFMEKVCAAADSEELTVEERNLLSVAYKNVIGARRASWRIIS
SIEQKEESRGNDDHVSTIRDYRSKIETELSNICGGILKLLDSRLIPSAASGDSKVFYLKMKGDYHRYLAE
FKTGAERKEAAESTLSAYKAAQDIANAELAPTHPIRLGLALNFSVFYYEILNSPDRACNLANEAFDEAIA
ELDTLEEESYKDSTLIMQLLRDNLTLWTSDNQDDGGDEIKEAAPKPDEQY

>1433_SPIOL 14-3-3-LIKE PROTEIN (FRAGMENT)
RNLLSVAYKNVVGARRASWRIISSIEQKEESRGNEDHVSVIRDYRSRIEKELSDNCDGILKLLDTKLVPA
ASSGDSKVFYLKMKGDYHRYLAEFKTGAQRKEAAESTLTAYKAAQDIANAELAPTHPIRLGLALNFSVFY
YEILNSPDRACNLAKQAFVEAIAELDTLGEDSYKDSTLIMQLLRDNLTLWTSDMQDEAADEITEEAAKQQ
KAVNNNKIAY

>1433_XENLA 14-3-3-LIKE PROTEIN (FRAGMENT)
AKLSEQAERYDDMAASMKAVTELGAELSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTEGNDKRQQMA
REYREKVETELQDICKDVLDLLDRFLVPNATPPESKVFYLKMKGDYYRYLSEVASGDSKQETVASSQQAY
QEAFEISKSEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKSAFDEAIRELDTLNEESYKDSTLIMQ
LLRDNLTLWTSENQGEEADNVEGDN

>1434_ARATH 14-3-3-LIKE PROTEIN GF14
MASGREELVYMAKLAEQAERYEEMVEFMEKVSAAVDGDELTVEERNLLSVAYKNVIGARRASWRIISSIE
QKEESRGNDDHVTAIREYRSKIETELSGICDGILKLLDSRLIPAAASGDSKVFYLKMKGDYHRYLAEFKT
GQERKDAAEHTLAAYKSAQDIANAELAPTHPIRLGLALNFSVFYYEILNSPDRACNLAKQAFDEAIAELD
TLGEESYKDSTLIMQLLRDNLTLWTSDMQDDAADEIKEAAAPKPTEEQQ

>1434_MAIZE 14-3-3-LIKE PROTEIN GF14-12
MAKLAEQAERYEEMVEFMEKVAKTVDSEELTVEERNLLSVAYKNVIGARRASWRIISSIEQKEEGRGNED
RVTLIKDYRGKIETELTKICDGILKLLESHLVPSSTAPESKVFYLKMKGDYYRYLAEFKTGAERKDAAEN
TMVAYKAAQDIALAELAPTHPIRLGLALNFSVFYYEILNSPDRACSLAKQAFDEAISELDTLSEESYKDS
TLIMQLLHDNLTLWTSDISEDPAEEIREAPKHDLSEGQ

>143B_BOVIN 14-3-3 PROTEIN BETA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1)
MDKSELVQKAKLAEQAERYDDMAAAMKAVTEQGHELSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTE
RNEKKQQMGKEYREKIEAELQDICNDVLQLLDKYLIPNATQPESKVFYLKMKGDYFRYLSEVASGDNKQT
TVSNSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLNEES
YKDSTLIMQLLRDNLTLWTSENQGDEGDAGEGEN

>143B_HUMAN 14-3-3 PROTEIN BETA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1) (PROTEIN 1054)
MDKSELVQKAKLAEQAERYDDMAAAMKAVTEQGHELSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTE
RNEKKQQMGKEYREKIEAELQDICNDVLELLDKYLIPNATQPESKVFYLKMKGDYFRYLSEVASGDNKQT
TVSNSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLNEES
YKDSTLIMQLLRDNLTLWTSENQGDEGDAGEGEN

>143B_RAT 14-3-3 PROTEIN BETA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1)
MDKSELVQKAKLAEQAERYDDMAAAMKAVTEQGHELSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTE
RNEKKQQMGKEYREKIEAELQDICSDVLELLDKYLILNATHAESKVFYLKMKGDYFRYLSEVASGDNKQT
TVSNSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLNEES
YKDSTLIMQLLRDNLTLWTSENQGDEGDAGEGEN

>143E_SHEEP 14-3-3 PROTEIN EPSILON (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1) (FRAGMENTS)
MDDREDLVYQAKLAEQAERYDEMVESMKKVAGMDVELTVEERNLLSVAYKNVIGARRASWRIISSIEQKE
ENKGGEDKLKMIREYRQMVETELKLICCDILDVLDKHLIPAANTGESKVFYYKMKGDYHRYLAEFATGND
RKEAAENSLVAYXXXXXXXXXXXXPTHPIRLGLALNFSVFYYEIXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXDSTLIMQLLRDNLTLWTSDMQGDGEEQNKEALQDVEDENQ

>143F_BOVIN 14-3-3 PROTEIN ETA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1)
GDREQLLQRARLAEQAERYDDMASAMKAVTELNEPLSNEDRNLLSVAYKNVVGARRSSWRVISSIEQKTM
ADGNEKKLEKVKAYREKIEKELETVCNDVLALLDKFLIKNCNDFQYESKVFYLKMKGDYYRYLAEVASGE
KKNSVVEASEAAYKEAFEISKEHMQPTHPIRLGLALNFSVFYYEIQNAPEQACLLAKQAFDDAIAELDTL
NEDSYKDSTLIMQLLRDNLTLWTSDQQDEEAGEGN

>143F_HUMAN 14-3-3 PROTEIN ETA (PROTEIN AS1) (FRAGMENT)
MKAVTELNEPLSNEDRNLLSVAYKNVVGARRSSWRVISSIEQKTMADGNEKKLEKVKAYREKIEKELETV
CNDVLSLLDKFLIKNCNDFQYESKVFYLKMKGDYYRYLAEVASGEKKTSVVEASEAAYKEAFEISKEQMQ
PTHPIRLGLALNFSVFYYEIQNAPEQACLLAKQAFDDAIAELDTLNEDSYKDSTLIMQL

>143G_BOVIN 14-3-3 PROTEIN GAMMA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1)
VDREQLVQKARLAEQAERYDDMAAAMKNVTELNEPLSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTS
ADGNEKKIEMVRAYREKIEKELEAVCQDVLSLLDNYLIKNCSETQIESKVFYLKMKGDYYRYLAEVATGE
KRATVVESSEKAYSEAHEISKEHMQPTHPIRLGLALNYSVFYYEIQNAPEQACHLAKTAFDDAIAELDTL
NEDSYKDSTLIMQLLRDNLTLWTSDQQDDDGGEGN

>143G_RAT 14-3-3 PROTEIN GAMMA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1)
VDREQLVQKARLAEQAERYDDMAAAMKNVTELNEPLSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTS
ADGNEKKIEMVRAYREKIEKELEAVCQDVLSLLDNYLIKNCSETQYESKVFYLKMKGDYYRYLAEVATGE
KRATVVESSEKAYSEAHEISKEHMQPTHPIRLGLALNYSVFYYEIQNAPEQACHLAKTAFDDAIAELDTL
NEDSYKDSTLIMQLLRDNLTLWTSDQQDDDGGEGNN

>143S_HUMAN 14-3-3 PROTEIN HOMOLOG STRATIFIN
MERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSN
EEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDK
KRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSE
DSYKDSTLIMQLLRDNLTLWTADNAGEEGGEAPQEPQS

>143T_HUMAN 14-3-3 PROTEIN THETA (14-3-3 PROTEIN T-CELL) (HS1 PROTEIN)
MEKTELIQKAKLAEQAERYDDMATCMKAVTEQGAELSNEERNLLSVAYKNVVGGRRSAWRVISSIEQKTD
TSDKKLQLIKDYREKVESELRSICTTVLELLDKYLIANATNPESKVFYLKMKGDYFRYLAEVACGDDRKQ
TIDNSQGAYQEAFDISKKEMQPTHPIRLGLALNFSVFYYEILNNPELACTLAKTAFDEAIAELDTLNEDS
YKDSTLIMQLLRDNLTLWTSDSAGEECDAAEGAEN

>143T_RAT 14-3-3 PROTEIN THETA
MEKTELIQKAKLAEQAERYDDMATCMKAVTEQGAELSNEERNLLSVAYKNVVGGRRSAWRVISSIEQKTD
TSDKKLQLIKDYREKVESELRSICTTVLELLDKYLIANATNPESKVFYLKMKGDYFRYLAEVACGDDRKQ
TIENSQGAYQEAFDISKKEMQPTHPIRLGLALNFSVFYYEILNNPELACTLAKTAFDEAIAELDTLNEDS
YKDSTLIMQLLRDNLTLWTSDSAGEECDAAEGAEN

>143Z_BOVIN 14-3-3 PROTEIN ZETA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1)
MDKNELVQKAKLAEQAERYDDMAAAMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTE
GAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKG
IVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEES
YKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN

>143Z_HUMAN 14-3-3 PROTEIN ZETA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1) (PHOSPHOLIPASE A2) (EC 3.1.1.4)
MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTE
GAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKG
IVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEES
YKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN

>143Z_RAT 14-3-3 PROTEIN ZETA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1)
MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTE
GAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQPESKVFYLKMKGDYYRYLAEVAAGDDKKG
IVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEES
YKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN

>143Z_SHEEP 14-3-3 PROTEIN ZETA (PROTEIN KINASE C INHIBITOR PROTEIN-1) (KCIP-1)
MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTE
GAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNRSQPESKVFYLKMKGDYYRYLAEVAAGDDKKG
IVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEES
YKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN

>14KD_DAUCA 14 KD PROTEIN
MGSKNSASVALFFTLNILFFALVSSTEKCPDPYKPKPKPTPKPTPTPYPSAGKCPRDALKLGVCADVLNL
VHNVVIGSPPTLPCCSLLEGLVNLEAAVCLCTAIKANILGKNLNLPIALSLVLNNCGKQVPNGFECT

>14KD_MYCTU 14 KD ANTIGEN (16 KD ANTIGEN) (HSP 16.3)
ATTLPVQRHPRSLFPEFSELFAAFPSFAGLRPTFDTRLMRLEDEMKEGRYEVRAELPGVDPDKDVDIMVR
DGQLTIKAERTEQKDFDGRSEFAYGSFVRTVSLPVGADEDDIKATYDKGILTVSVAVSEGKPTEKHIQIR
STN

>14KD_RHOSH 14 KD PEPTIDE OF UBIQUINOL-CYTOCHROME C2 OXIDOREDUCTASE COMPLEX (EC 1.10.2.2)
MFSFIDDIPSFEQIKARVRDDLRKHGWEKRWNDSRLVQKSRELLNDEELKIDPATWIWKRMPSREEVAAR
RQRDFETVWKYRYRLGGFASGALLALALAGIFSTGNFGGSSDAGNRPSVVYPIE

>170K_TRVPS POTENTIAL 170 KD PROTEIN (FRAGMENT)
GAHLVPTKSGDADTYNANSDRTLCALLSELPLEKAVMVTYGGDDSLIAFPRGTQFVDPCPKLATKWNFEC
KIFKYDVPMFCGKFLLKTSSCYEFVPDPVKVLTKLGKKSIKDVQHLAEIYISLNDSNRALGNYMVVSKLS
ESVSDRYLYKGDSVHALCALWKHIKSFTALCTLLPRRKG

>17KD_BACSU 17 KD PROTEIN IN DNAX 5'REGION
MTQDELYMKEAIKEAKKAEEKGEVPIGAVLVINGEIIARAHNLRETEQRSIAHAEMLVIDEACKALGTWR
LEGATLYVTLEPCPMCAGAVVLSRVEKVVFGAFDPKGGCSGTLMNLLQEERFNHQAEVVSGVLEEECGGM
LSAFFRELRKKKKAARKNLSE

>17KD_RICCA 17 KD ANTIGEN (FRAGMENT)
GSQFGKGKGQLIGVGAGALLGAILGNQIGAGMDEQDRRLAELTSQRALETTPSGTSIEWRNPDNGNYGYV
TPSKTYKNST

>17K_RICPR 17 KD ANTIGEN PRECURSOR
MKLLSKIMIIALAASMLQACNGQSGMNKQGTGTLLGGAGGALLGSQFGQGKGQLVGVGVGALLGAVLGGQ
IGASMDEQDRRLLELTSQRALESAPSGSNIEWRNPDNGNHGYVTPNKTYRNSAGQYCREYTQTVIIGGKQ
QKTYGNACRQPDGQWQVVN

>17K_RICRI 17 KD ANTIGEN PRECURSOR
MKLLSKIMIIALATSMLQACNGPGGMNKQGTGTLLGGAGGALLGSQFGKGKGQLVGVGVGALLGAVLGGQ
IGAGMDEQDRRLAELTSQRALETAPSGSNVEWRNPDNGNYGYVTPNKTYRNSTGQYCREYTQTVVIGGKQ
QKAYGNACRQPDGQWQVVN

>17K_RICTY 17 KD ANTIGEN PRECURSOR
MKLLSKVMILALAASMLQACNGPGGMNKQGTGTLLGGAGGALLGSQFGHGKGQLVGVGVGALLGAVLGGQ
IGASLDEQDRKLLELTSQRALESAPSGSNIEWRNPDNGNHGYVTPNKTYRNSTGQYCREYTQTVVIGGKQ
QTTYGNACRQPDGQWQVVN

>18C_DROME HISTONE-LIKE PROTEIN 18C
MSNLKQKDSKPEVAVTKSVKTYKKSIEYVNSDASDIEEDINRAEDEYASSSGFVNFLRDFKKRYGEYYSN
NEIRRAAETRWNEMSFRHRCQYSAEPLDTFHVEPNSVSSLQRSSEGEHRMHSEISGCADTFFGAGGSNSC
TPRKENKCSKPRVRKSCPKPRAKTSKQRRSCGKPKPKGARPRKACPRPRKKMECGKAKAKPRCLKPKSSK
PKCSM

>18KD_BACSU 18 KD COMPETENCE-SPECIFIC PROTEIN
MIKSWKPQELSISYHQFTVFQKDSTPPVMDWTDEAIEKGYAAADGAISFEAQRNTKAFILFRLNSSETVN
SYEKKVTVPFHVTENGIHIESIMSKRLSFDLPKGDYQLTCWTVPAEMSDLHADTYIIDAVSV

>18KD_MYCLE 18 KD ANTIGEN (HSP 16.7)
MLMRTDPFRELDRFAEQVLGTSARPAVMPMDAWREGEEFVVEFDLPGIKADSLDIDIERNVVTVRAERPG
VDPDREMLAAERPRGVFNRQLVLGENLDTERILASYQEGVLKLSIPVAERAKPRKISVDRGNNGHQTINK
TAHEIIDA

>190K_RICRI 190 KD ANTIGEN PRECURSOR (CELL SURFACE ANTIGEN)
MANISPKLFKKAIQQGLKAALFTTSTAAIMLSSSGALGVATGVIATNNNAAFSNNVGNNNWNEITAAGVA
NGTPAGGPQNNWAFTYGGDYTVTADAADRIIKAINVAGTTPVGLNITQNTVVGSIITKGNLLPVTLNAGK
SLTLNGNNAVAANHGFDAPADNYTGLGNIALGGANAALIIQSAAPSKITLAGNIDGGGIITVKTDAAING
TIGNTNALATVNVGAGTATLGGAVIKATTTKLTNAASVLTLTNANAVLTGAIDNTTGGDNVGVLNLNGAL
SQVTGDIGNTNSLATISVGAGTATLGGAVIKATTTKLTDAASAVKFTNPVVVTGAIDNTGNANNGIVTFT
GNSTVTGNVGNTNALATVNVGAGLLQVQGGVVKANTINLTDNASAVTFTNPVVVTGAIDNTGNANNGIVT
FTGNSTVTGDIGNTNALATVNVGAGTATLGGAVIKATTTKLTNAASVLTLTNANAVLTGAIDNTTGGDNV
GVLNLNGALSQVTGNIGNTNSLATISVGAGTATLGGAVIKATTTKLTDAASAVKFTNPVVVTGAIDNTGN
ANNGIVTFTGNSTVTGDIGNTNSLATISVGAGTATLGGAVIKATTTKLTNAASVLTLTNANAVLTGAIDN
TTGGDNVGVLNLNGALSQVTGDIGNTNSLATISVGAGTATLGGAVIKATTTKITNAVSAVKFTNPVVVTG
AIDSTGNANNGIVTFTGNSTVTGDIGNTNALATVNVGAGTATLGGAVIKATTTKLTNAASVLTLTNANAV
LTGAIDNTTGGDNVGVLNLNGALSQVTGDIGNTNSLATISVGAGTATLGGAVIKATTTKLTNAASVLTLT
NANAVLTGAVDNTTGGDNVGVLNLNGALSQVTGDIGNTNSLATISVGAGTATLGGAVIKATTTKLTNAAS
VLTLTNANAVLTGAIDNTTGGDNVGVLNLNGALSQVTGDIGNTNSLATISVGAGTATLGGAVIKATTTKL
TDAASAVKFTNPVVVTGAIDNTGNANNGIVTFTGNSTVTGNVGNTNALATVNVGAGLLQVQGGVVKANTI
NLTDNASAVTFTNPVVVTGAIDNTGNANNGIVTFTGNSTVTGNVGNTNALATVNVGAGLLQVQGGVVKAN
TINLTDNASAVTFTNPVVVTGAIDNTGNANNGIVTFTGNSTVTGDIGNTNALATVNVGAGITLQAGGSLA
ANNIDFGARSTLEFNGPLDGGGKAIPYYFKGAIANGNNAILNVNTKLLTASHLTIGTVAEINIGAGNLFT
IDASVGDVTILNAQNINFRARDSVLVLSNLTGVGVNNILLAADLVAPGADEGTVVFNGGVNGLNVGSNVA
GTARNIGDGGGNKFNTLLIYNAVTITDDVNLEGIQNVLINKNADFTSSTAFNAGAIQINDATYTIDANNG
NLNIPAGNIQFAHADAQLVLQNSSGNDRTITLGANIDPDNDDEGIVILNSVTAGKKLTIAGGKTFGGAHK
LQTILFKGAGDCSTAGTTFNTTNIVLDITGQLELGATTANVVLFNDAVQLTQTGNIGGFLDFNAKNGMVT
LNNNVNVAGAVQNTGGTNNGTLIVLGASNLNRVNGIAMLKVGAGNVTIAKGGKVKIGEIQGTGTNTLTLP
AHFNLTGSINKTGGQALKLNFMNGGSVSGVVGTAANSVGDITTAGATSFASSVNAKGTATLGGTTSFANT
FTNTGAVTLAKGSITSFAKNVTATSFVANSATINFSNSLAFNSNITGGGTTLTLGANQVTYTGTGSFTDT
LTLNTTFDGAAKSGGNILIKSGSTLDLSGVSTLALVVTATNFDMNNISPDTKYTVISAETAGGLKPTSKE
NVKITINNDNRFVDFTFDASTLTLFAEDIAADVIDGDFAPGGPLANIPNAANIKKSLELMEDAPNGSDAR
QAFNNFGLMTPLQEADATTHLIQDVVKPSDTIAAVNNQVVASNISSNITALNARMDKVQSGNKGPVSSGD
EDMDAKFGAWISPFVGNATQKMCNSISGYKSDTTGGTIGFDGFVSDDLALGLAYTRADTDIKLKNNKTGD
KNKVESNIYSLYGLYNVPYENLFVEAIASYSDNKIRSKSRRVIATTLETVGYQTANGKYKSESYTGQLMA
GYTYMMPENINLTPLAGLRYSTIKDKGYKETGTTYQNLTVKGKNYNTFDGLLGAKVSSNINVNEIVLTPE
LYAMVDYAFKNKVSAIDARLQGMTAPLPTNSFKQSKTSFDVGVGVTAKHKMMEYRINYDTNIGSKYFAQQ
GSVKVRVNF

>194K_TRVSY POTENTIAL 194 KD PROTEIN (PUTATIVE REPLICASE) (CONTAINS: 134 KD PROTEIN)
MANGNFKLSQLLNVDEMSAEQRSHFFDLMLTKPDCEIGQMMQRVVVDKVDDMIRERKTKDPVIVHEVLSQ
rKEQNKLMEIYPEFNIVFKDDKNMVHGFAAAERKLQALLLLDRVPALQEVDDIGGQWSFWVTRGEKRIHS
CCPNLDIRDDQREISRQIFLTAIGDQARSGKRQMSENELWMYDQFRKNIAAPNAVRCNNTYQGCTCRGFS
DGKKKGAQYAIALHSLYDFKLKDLMATMVEKKTKVVHAAMLFAPESMLVDEGPLPSVDGYYMKKNGKIYF
GFEKDPSFSYIHDWEEYKKYLLGKPVSYQGNVFYFEPWQVRGDTMLFSIYRIAGVPRRSLSSQEYYRRIY
ISRWENMVVVPIFDLVESTRELVKKDLFVEKQFMDKCLDYIARLSDQQLTISNVKSYLSSNNWVLFINGA
AVKNKQSVDSRDLQLLAQTLLVKEQVARPVMRELREAILTETKPITSLTDVLGLISRKLWKQFANKIAVG
GFVGMVGTLIGFYPKKVLTWAKDTPNGPELCYENSHKTKVIVFLSVVYAIGGITLMRRDIRDGLVKKLCD
MFDIKRGAHVLDVENPCRYYEINDFFSSLYSASESGETVLPDLSEVKAKSDKLLQQKKEIADEFLSAKFS
NYSGSSVRTSPPSVVGSSRSGLGLLLEDSNVLTQARVGVSRKVDDEEIMEQFLSGLIDTEAEIDEVVSAF
SAECERGETSGTKVLCKPLTPPGFENVLPAVKPLVSKGKTVKRVDYFQVMGGERLPKRPVVSGDNSVDAR
REFLYYLDAERVAQNDEIMSLYRDYSRGVIRTGGQNYPHGLGVWDVEMKNWCIRPVVTEHAYVFQPDKRM
DDWSGYLEVAVWERGMLVNDFAVERMSDYVIVCDQTYLCNNRLILDNLSALDLGPVNCSFELVDGVPGCG
KSTMIVNSANPCVDVVLSTGRAATDDLIERFASKGFPCKLKRRVKTVDSFLMHCVDGSLTGDVLHFDEAL
MAHAGMVYFCAQIAGAKRCICQGDQNQISFKPRVSQVDLRFSSLVGKFDIVTEKRETYRSPADVAAVLNK
YYTGDVRTHNATANSMTVRKIVSKEQVSLKPGAQYITFLQSEKKELVNLLALRKVAAKVSTVHESQGETF
KDVVLVRTKPTDDSIARGREYLIVALSRHTQSLVYETVKEDDVSKEIRESAALTKAALARFFVTETVLXR
FRSRFDVFRHHEGPCAVPDSGTITDLEMWYDALFPGNSLRDSSLDGYLVATTDCNLRLDNVTIKSGNWKD
KFAEKETFLKPVIRTAMPDKRKTTQLESLLALQKRNQAAPDLQENVHATVLIEETMKKLKSVVYDVGKIR
ADPIVNRAQMERWWRNQSTAVQAKVVADVRELHEIDYSSYMYMIKSDVKPKTDLTPQFEYSALQTVVYHE
KLINSLFGPIFKEINERKLDAMQPHFVFNTRMTSSDLNDRVKFLNTEAAYDFVEIDMSKFDKSANRFHLQ
LQLEIYRLFGLDEWAAFLWEVSHTQTTVRDIQNGMMAHIWYQQKSGDADTYNANSDRTLCALLSELPLEK
AVMVTYGGDDSLIAFPRGTQFVDPCPKLATKWNFECKIFKYDVPMFCGKFLLKTSSCYEFVPDPVKVLTK
LGKKSIKDVQHLAEIYISLNDSNRALGNYMVVSKLSESVSDRYLYKGDSVHALCALWKHIKSFTALCTLF
RDENDKELNPAKVDWKKAQRAVSNFYDW

>19KD_MYCTU 19 KD LIPOPROTEIN ANTIGEN PRECURSOR
MKRGLTVAVAGAAILVAGLSGCSSNKSTTGSGETTTAAGTTASPGAASGPKVVIDGKDQNVTGSVVCTTA
AGNVNIAIGGAATGIAAVLTDGNPPEVKSVGLGNVNGVTLGYTSGTGQGNASATKDGSHYKITGTATGVD
MANPMSPVNKSFEIEVTCS

>1A01_GORGO CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-A0101 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDRNTRNVKAHSQTDRVDLGTLRGYYNQSEDGSHTIQRMYGCDVGSDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAEITKRKWEAAHFAEQLRAYLEGTCVEWLRRHLENGKETLQRTDAPK
THMTHHAVSDHEAILRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQR
YTCHVQHEGLPEPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVVAAVRWRRKSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-1 A0101 ALPHA CHAIN PRECURSOR
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQKME
PRAPWIEQEGPEYWDQETRNMKAHSQTDRANLGTLRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAADMAAQITKRKWEAVHAAEQRRVYLEGRCVDGLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASS
DSAQGSDVSLTACKV

>1A01_PANTR CHLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN PRECURSOR
MAVMPPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDEETRSAKAHSQTDRVDLGTLRGYYNQSEDGSHTIQIMYGCDVGSDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAADMAAQITKRKWEAAHAAEQRRAYLEGTCVEWLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASS
DSAQGSDVSLTACKV

>1A01_PONPY CLASS I HISTOCOMPATIBILITY ANTIGEN, A-1 ALPHA CHAIN PRECURSOR
MAIMAPRTLLLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRTPWMEQEGPEYWDRETRSVKAHAQTNRVDLGTLRGYYNQSDGGSHTIQRMFGCDVGPDGRFLRGYEQH
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAAGAAEQDRAYLEGLCVESLRRYLENGKETLQRTDAPK
THMTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGKEQR
YTCHVQHEGLPEPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRRNSDRKGGSYSQAASN
DSAQGSDVSLTACKV

>1A01_SAGOE CLASS I HISTOCOMPATIBILITY ANTIGEN, A ALPHA CHAIN PRECURSOR
MTVMAPRTLLLLLSGALVLTETWAGSHSMRYFETSVSRPGRGEPRYISVGYVDDTQFVRFDSDAASPRME
PRAPWMEQEGPEYWEEETRKGKADAQTFRVDLQTLLGYYNQSEAGSHTIQWMYGCDLGPDGRLLRGYDQH
AYDGKDYIALNEDLRSWTATDVAAQITQRKWEAANEAERTRAYLEGTCVEWLHRYLENGKETLQRAEPPK
THVTHHPVSDHEATLRCWALGFYPAEITVTWQRDGEDQTQDMELVETRPAGDGTFQKWAAVVVLSGEEQR
YTCHVQHEGLPEPLTLRWEPPSQPTIPIMGIVAILAILGVVVTGAVVAAVMWRKKSSDKKGGSYSQAARS
DSAQGSDVSLTACKV

>1A02_GORGO CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-A0201 ALPHA CHAIN PRECURSOR
MAVMAPRTLLLLLLGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEEPEYWDGETRKVKAHSQTDRVNLGTLRGYYNQSEAGSHTIQKMYGCDVGSDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAEITKRKWEAAHFAEQLRAYLEGECVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEAILRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQR
YTCHVQHESLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVIAAVRWRRKSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 A0201 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQY
AYDGKDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVITGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A02_PANTR CHLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-5 ALPHA CHAIN PRECURSOR
MQVTAPRTVLLLLSAALALTETWAGSHSMKYFYTAVSRPGRGEPRFISVGYVDDTQFVWFDSDAASPREE
PRAPWIEQEGPEYWDRETQISKTNAQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDMGPDGRLLRGYEQY
AYDGKDYIALNQDLSSWTAADTAAQITQRKWEAARWAEQLRAYLEGTCVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1A03_GORGO CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-A0401 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEEPEYWDGETRNMKARSQTDRVDLGTLRGYYNQSEDGSHTIQRMYGCDVGSDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAAHEAEQLRAYLEGTCVEWLRRYLENGKETLQLTDAPK
THMTHHPVSDHEAILRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVVAAVRWRRKSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A03_PANTR CHLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-108 ALPHA CHAIN PRECURSOR
MAVMPPRTLLLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDQETRNMKASAQTDRVDLGTLRGYYNQSEDGSHTIQIMYGCDVGSDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAAAMAAQITKRKWEAAHAAEQLRAYLEGRCVEWLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAVITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASS
DSAQGSDVSLTACKV

>1A04_GORGO CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-A0501 ALPHA CHAIN PRECURSOR
MAVVAPRTLLLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWMEQEEPEYWDRQTQISKTNAQIELESLRIALRYYNQSEDGSHTIQRMYGCDVGSDGRFLRGYQQD
AYDGKDYIASNEDLRSWTAADMAAEITKRKWEAAHFAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THTTHQAVSDHEATLKCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVVAAVRWRRKSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A04_PANTR CHLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-126 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDEETRSVKASAQTDRVDLGTLRGYYNQSEDGSHTIQLMFGCDVGSDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAAHAAEQLRAYLEGTCVEWLRRYLENGKETLQRTDPPK
THMTHHPISDREATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A05_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 A0204 ALPHA CHAIN PRECURSOR (FRAGMENT)
LVLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQ
EGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQMMYGCDVGSDWRFLRGYHQYAYDGKDYI
ALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAV
SDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHVQHE
GLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVITGAVVAAVMWRRKSSDRKGGSYSQAASSDSAQGSDV
SLTACKV

>1A07_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 A0206 ALPHA CHAIN PRECURSOR (A2.4A)
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQY
AYDGKDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVITGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A11_CUCMA 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE)
MEFHQIDERNQALLSKIAVDDGHGENSPYFDGWKAYDNDPFHPEDNPLGVIQMGLAENQLSFDMIVDWIR
KHPEASICTPKGLERFKSIANFQDYHGLPEFRNGIASFMGKVRGGRVQFDPSRIVMGGGATGASETVIFC
LADPGDAFLVPSPYYAAFDRDLKWRTRAQIIRVHCNSSNNFQVTKAALEIAYKKAQEANIKVKGVIITNP
SNPLGTTYDRDTLKTLVTFVNQHDIHLICDEIYSATVFKAPTFISIAQIVEEMEHCKKELIHILYSLSKD
MGLPGFRVGIIYSYNDVVVRRARQMSSFGLVSSQTQHLLAAMLSDEDFVDKFLAENSKRLAERHARFTKE
LDKMGITCLNSNAGVFVWMDLRRLLKDQTFKAEMELWRVIINEVKLNVSPGSSFHVTEPGWFRVCFANMD
DNTVDVALNRIHSFVENIDKKEDNTVAMPSKTRRRENKLRLSFSFSGRRYDEGNVLNSPHTMSPHSPLVI
AKN

>1A11_CUCPE 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE 1 (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE)
MGFHQIDERNQALLSKIALDDGHGENSPYFDGWKAYDNDPFHPENNPLGVIQMGLAENQLSFDMIVDWIR
KHPEASICTPEGLERFKSIANFQDYHGLPEFRNAIANFMGKVRGGRVKFDPSRIVMGGGATGASETVIFC
LADPGDAFLVPSPYYAGFDRDLKWRTRAQIIRVHCNGSNNFQVTKAALEIAYKKAQEANMKVKGVIITNP
SNPLGTTYDRDTLKTLVTFVNQHDIHLICDEIYSATVFKAPTFTSIAEIVEQMEHCKKELIHILYSLSKD
MGLPGFRVGIIYSYNDVVVRRARQMSSFGLVSSQTQHLLAAMLSDEDFVDKFLAENSKRVGERHARFTKE
LDKMGITCLNSNAGVFVWMDLRRLLKDQTFKAEMELWRVIINEVKLNVSPGSSFHVTEPGWFRVCFANMD
DNTVDVALNRIHSFVENIDKKEDNTVAMPSKTRHRDNKLRLSFSFSGRRYDEGNVLNSPHTMSPHSPLVI
AKN

>1A11_LYCES 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE 1 (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE)
MGFEIAKTNSILSKLATNEEHGENSPYFDGWKAYDSDPFHPLKNPNGVIQMGLAENQLCLDLIEDWIKRN
PKGSICSEGIKSFKAIANFQDYHGLPEFRKAIAKFMEKTRGGRVRFDPERVVMAGGATGANETIIFCLAD
PGDAFLVPSPYYPAFNRDLRWRTGVQLIPIHCESSNNFKITSKAVKEAYENAQKSNIKVKGLILTNPSNP
LGTTLDKDTLKSVLSFTNQHNIHLVCDEIYAATVFDTPQFVSIAEILDEQEMTYCNKDLVHIVYSLSKDM
GLPGFRVGIIYSFNDDVVNCARKMSSFGLVSTQTQYFLAAMPSDEKFVDNFLRESAMRLGKRHKHFTNGL
EVVGIKCLKNNAGLFCWMDLRPLLRESTFDSEMSLWRVIINDVKLNVSLGSSFECQEPGWFRVCFANMDD
GTVDIALARIRRFVGVEKSGDKSSSMEKKQQWKKNNLRLSFSKRMYDESVLSPLSSPIPPSPLVR

>1A12_CUCMA 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE)
MKMLSTKATCNSHGQDSSYFLGWEAYENNPFHHTSNPNGIIQMGLAENQLSFDLLESWLSKNPDAASFKR
DGKSIFRELALFQDYHGLPAFKKALVEFMAEIRGNKVSFEANNIVLTAGATSANETLMFCLAEAGDAFLL
PTPYYPGFDRDLKWRTGVEIVPIHCTSSNGFQITQSALEQAYKDAQTRNLRVKGVLVTNPSNPLGTTMNR
DELNLVFDFITSKGIHLISDEIYSGTVFGSPGFVSAMEVLKERSSEDEEVWKRVHIVYSLSKDLGLPGFR
VGAIYSNDDMVVAAATKMSSFGLVSSQTQYLLSAMLSDKKFTISYISENQKRLKQRQKMLVSGLQKAGIN
CLDSNAGLFCWVDMRHLLESDKFESELELWKKIVYEVGLNISPGSSCHCTEPGWFRVCFANMSESTLKLA
VRRLKSFVTELRSTTTSNHRNHDNKICKNIKKNIFTKWVFRQSAQEANRKMQAER

>1A12_CUCPE 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE 2 (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE)
MGFHQIDERNQALLSKIAIDDGHGENSAYFDGWKAYDNNPFHPENNPLGVIQMGLAENQLSFGMIVDWIR
KHPEASICTPEGLEKFKSIANFQDYHGLQEFRKAMASFMGKVRGGRVKFDPSRIVMGGGATGASETVIFC
LADPGDAFLVPSPYYAAFDRDLKWRTRAQIIPVHCNSSNNFQVTEAALEIAYKKAQEANMKVKGVIITNP
SNPLGTTYDRDTLKTLVTFVNQHDIHLICDEIYSATVFKAPTFTSIAEIVEQMEHCKKELIHILYSLSKD
MGLPGFRVGIIYSYNDVVVRRARQMSSFGLVSSQTQHLLAAMLSDEDFVDKFLAENSKRLGERHARFTKE
LDKMGITCLNSNAGVFVWMDLRRLLKDQTFKAEMELWRVIINEVKLNVSPGSSFHVTEPGWFRVCFANMD
DNTVDVALNRIHSFVENIDKKEDNTVAMPSKTRHRDNKLRLSFSFSGRRYDKGNVLNSPHTMSPHSPLVR
ARTY

>1A12_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 A0211 ALPHA CHAIN PRECURSOR (A2.5) (FRAGMENT)
LVLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQ
EGPEYWDGETRKVKAHSQIDRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDGKDYI
ALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAV
SDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHVQHE
GLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVITGAVVAAVMWRRKSSDRKGGSYSQAASSDSAQGSDV
SLTACKV

>1A12_LYCES 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE 2 (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE)
MDLETSEISNYKSSVVLSKLASNEQHGENSPYFDGWKAYDNDPFHLVNNLNGVIQMGLAENQLSVDLIEE
WIKRNPKASICTNDGIESFRRIANFQDYHGLPEFTNAIAKFMEKTRGGKVKFDAKRVVMAGGATGANETL
ILCLADPGDAFLVPTPYYPGFNRDLRWRSGVQLLPISCKSCNNFKITIEAIEEAYEKGQQANVKIKGLIL
TNPCNPLGTILDRDTLKKISTFTNEHNIHLVCDEIYAATVFNSPKFVSIAEIINEDNCINKDLVHIVSSL
SKDLGFPGFRVGIVYSFNDDVVNCARKMSSFGLVSTQTQHLLAFMLSDDEFVEEFLIESAKRLRERYEKF
TRGLEEIGIKCLESNAGVYCWMDLRSLLKEATLDAEMSLWKLIINEVKLNVSPGSSFNCSEVGWFRVCFA
NIDDQTMEIALARIRMFMDAYNNVNKNGVMKNKHNGRGTTYDLTPQMGSTMKMLLA

>1A13_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 A0212 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQY
AYDGKDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQQRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVITGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A14_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 A0301 ALPHA CHAIN PRECURSOR (A-3.1)
MARGDQAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAA
SQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLR
GYRQDAYDGKDYIALNEDLRSWTAADMAAQITKRKWEAAHEAEQLRAYLDGTCVEWLRRYLENGKETLQR
TDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPS
GEEQRYTCHVQHEGLPKPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYT
QAASSDSAQGSDVSLTACKV

>1A16_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 A1101/A1102 ALPHA CHAIN PRECURSOR (A-11E/A-11K)
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAADMAAQITKRKWEAAHAAEQQRAYLEGRCVEWLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASS
DSAQGSDVSLTACKV

>1A17_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-23(A-9) A2301 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDEETGKVKAHSQTDRENLRIALRYYNQSEAGSHTLQMMFGCDVGSDGRFLRGYHQY
AYDGKDYIALKEDLRSWTAADMAAQITQRKWEAARVAEQLRAYLEGTCVDGLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQPTVHIVGIIAGLVLLGAVITGAVVAAVMWRRNSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A18_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-24(A-9) A2401 ALPHA CHAIN PRECURSOR (AW-24)
MAVMGPRTLVLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDEETGKVKAHSQTDRENLRIALRYYNQSEAGSHTLQMMFGCDVGSDGRFLRGYHQY
AYDGKDYIALKEDLRSWTAADMAAQITKRKWEAAHVAEQQRAYLEGTCVDGLRRYLENGKETLQRADPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQPTVPIVGIIAGLVLLGAVITGAVVAAVMWRRNSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A19_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-24(A-9) A2402 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDEETGKVKAHSQTDRENLRIALRYYNQSEAGSHTLQMMFGCDVGSDGRFLRGYHQY
AYDGKDYIALKEDLRSWTAADMAAQITKRKWEAAHVAEQQRAYLEGTCVDGLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQPTVPIVGIIAGLVLLGAVITGAVVAAVMWRRNSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A1C_DIACA 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE)
MGSYKGVYDREILSKIATNDGHGENLEYFDGWKAYDRDPYHSTKNSNGVIQMGLAENQLCFDLVTEWLLK
NPQASICTNEGVNKFMDIAIFQDYHGLPEFRSAVAKFMGKARDEKVIFNPDRIVMSGGASASETLLFCLA
NPGDAFLIPSPYYPAFNRDLRWRTGVNLIPFTCSSSNNFKITKEALQSAYEDALKKNIKVKGIIVTNPSN
PLGTVLDKDTLKMLLTFVNAKNIHLVCDEIYATTVFNSPSFISVAEVIKDMPHVNQDLVHILYSLSKDMG
MPGFRVGIIYSYNDRVVSTARRMSSFGLVSSQTQFMIAALLSDDDFVRRFLVESRDRLFRRHQHFTSELA
KIGIGCLQGNAALFVWMDLRHLLDEATVERELKLWRVIINEVKINVSPGSSFLCSEPGWFRVCFANMDNA
TLDVALNRIRSFVTRGRVDNSTMTTTSARAAATTTTTTTTTTTTTTTTTTIKKKRGQMELRLSFNNRRFE
DGLMSPHSILLSPHSPMPQSPLVKART

>1A1C_PHAAU 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE) (FRAGMENT)
QMGLAENQLTSDLVEDWILNNPEASICTPEGINDFRAIANFQDYHGLAEFRNAVAKFMARTRGNRITFDP
DRIVMSGGATGAHEVTAFCLADPGEAFLVPIPYYPGFDRDLRWRTGVKLVPVMCDSSNNFVLTKEALEDA
YEKAREDNIRVKGLLITNPSNPLGTIMDRKTLRTVVSFINEKRIHLVCDEIYAATVFSQPGFISIAEILE
DETDIECDRNLVHIVYSLSKDMGFPGFRVGIIYSYNDAVVNCARKMSSFGLVSTQTQYLLASMLNDDEFV
ERFLAESAKRLAQRFRVFTGGLAKVGIKCLQSNAGLFVWMDLRQLLKKPTFDSETELWKVIIHEVKINVS
PGYSFHCTEPGWFRVCFA

>1A1C_SOYBN 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE (EC 4.4.1.14) (ACC SYNTHASE) (S-ADENOSYL-L-METHIONINE METHYLTHIOADENOSINE-LYASE)
MGLMDVDQTQLLSKMVIGDGHGEASPYFDGWKAYDENPFHPKENPNGVIQMGLAENQLTSDLVEDWILNN
PEASICTPEGINDFRAIANFQDYHGLPEFRNAVAKFMGRTRGNRVTFDPDRIVMSGGATGAHEVTTFCLA
DPGDAFLVPIPYYPGFDRDLRWRTGIKLVPVMCDSSNNFKLTKQALEDAYEKAKEDNIRVKGLLITNPSN
PLGTVMDRNTLRTVMSFINEKRIHLVSDEIYSATVFSHPSFISIAEILEEDTDIECDRNLVHIVYSLSKD
MGFPGFRVGIIYSYNDAVVHCARKMSSFGLVSTQTQYLLASMLNDDEFVESFLVESAKRLAQRHRVFTGG
LAKVGIKCLQSNAGLFVWMDLRQLLKKPTLDSEMELWRVIIDEVKINVSPGSSFHCTEPGWFRVCYANMD
DMAVQIALQRIRNFVLQNKEIMVPNKKHCWHSNLRLSLKTRRFDDIMMSPHSPIPQSPLVKATI

>1A1D_PSESP 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE (EC 4.1.99.4) (ACC DEAMINASE)
MNLQRFPRYPLTFGPTPIQPLARLSKHLGGKVHLYAKREDCNSGLAFGGNKTRKLEYLIPEALAQGCDTL
VSIGGIQSNQTRQVAAVAAHLGMKCVLVQENWVNYSDAVYDRVGNIQMSRILGADVRLVPDGFDIGFRRS
WEDALESVRAAGGKPYAIPAGCSDHPLGGLGFVGFAEEVRAQEAELGFKFDYVVVCSVTGSTQAGMVVGF
AADGRADRVIGVDASAKPAQTREQITRIARQTAEKVGLERDIMRADVVLDERFAGPEYGLPNEGTLEAIR
LCARTEGMLTDPVYEGKSMHGMIEMVRNGEFPEGSRVLYAHLGGVPALNGYSFIFRDG

>1A20_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-24(A-9) A2403 ALPHA CHAIN PRECURSOR (A9.3)
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFSTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDEETGKVKAHSQTDRENLRIALRYYNQSEAGSHTLQMMFGCDVGSDGRFLRGYHQY
AYDGKDYIALKEDLRSWTAADMAAQITKRKWEAAHVAEQQRAYLEGTCVEWLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQPTVPIVGIIAGLVLLGAVITGAVVAAVMWRRNSSDRKGGSYSQAASS
DSAQGSDVSLTACKV

>1A21_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-25(A-10) A2501 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDRNTRNVKAHSQTDRESLRIALRYYNQSEDGSHTIQRMYGCDVGPDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWETAHEAEQWRAYLEGRCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1A22_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-26(A-10) A2601 ALPHA CHAIN (FRAGMENT)
HSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDRNTRNVKAHSQ
TDRANLGTLRGYYNQSEDGSHTIQRMYGCDVGPDGRFLRGYQQDAYDGKDYIALNEHLRSWTAGDMAAQI
TQRKWETAHEAEQWRAYLEGRCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYPAE
ITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQRYTCHVQHEGLPKPLTLRWEPSSQPTI
PIVGIIAGLVLFGAVIAGAVVAAVMWRRKSSDRKGGSYSQAASSDSAQGSDMSLTACKV

>1A23_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-29(AW-19) A2901 ALPHA CHAIN PRECURSOR
MAVMAPRTLLLLLLGALALTQTWAGSHSMRYFTTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDLQTRNVKAQSQTDRANLGTLRGYYNQSEAGSHTIQMMYGCHVGSDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVFAGAVVAAVRWRRKSSDRKGGSYFQAASS
DSAQGSDMSLTACKV

>1A24_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-29(AW-19) A2902 ALPHA CHAIN PRECURSOR (A29.2)
MAVMAPRTLLLLLLGALALTQTWAGSHSMRYFTTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDLQTRNVKAQSQTDRANLGTLRGYYNQSEAGSHTIQMMYGCDVGSDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVFAGAVVAAVRWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1A25_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-30(AW-19) A3001 ALPHA CHAIN PRECURSOR (A30.3)
MAVMAPRTLLLLLSGALALTHTWAGSHSMRYFFTSVSRPGSGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQERPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYEQH
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARWAEQLRAYLEGTCVEWLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASS
DSAQGSDVSLTACKV

>1A26_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-30(AW-19) A3002 ALPHA CHAIN PRECURSOR
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFSTSVSRPGSGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQERPEYWDQETRNVKAHSQTDRENLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYEQH
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARRAEQLRAYLEGTCVEWLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASS
DSAQGSDVSLTACKV

>1A27_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-31(AW-19) A3101 ALPHA CHAIN PRECURSOR
MAVMAPRTLLLLLLGALALTQTWAGSHSMRYFTTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQERPEYWDQETRNVKAHSQIDRVDLGTLRGYYNQSEAGSHTIQMMYGCDVGSDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDPPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVFAGAVVAAVRWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1A28_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-32(AW-19) A3201 ALPHA CHAIN (FRAGMENT)
GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAH
SQTDRESLRIALRYYNQSEAGSHTIQMMYGCDVGPDGRLLRGYQQDAYDGKDYIALNEDLRSWTAADMAA
QITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYP
AEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQRYTCHVQHEGLPKPLTLRW

>1A29_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-33(AW-19) A3301 ALPHA CHAIN PRECURSOR (AW-33.1)
MAVMAPRTLLLLLLGALALTQTWAGSHSMRYFTTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDRNTRNVKAHSQIDRVDLGTLRGYYNQSEAGSHTIQMMYGCDVGSDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARVADELRAYLEGTCVEWLRRHLENGKETLQRTDPPR
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVFAGAVVAAVRWRRKSSDRKGGSYFQAASS
DSAQGSDMSLTACKV

>1A30_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-34(A-10) A3401 ALPHA CHAIN PRECURSOR (AW34.1)
MAIMAPRTLVLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDRNTRKVKAQSQTDRVDLGTLRGYYNQSEDGSHTIQRMYGCDVGPDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWETAHEAEQWRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGILAGLVLFGAVIAGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1A31_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-34(A-10) A3402 ALPHA CHAIN PRECURSOR (AW34.2)
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDRNTRNVKAQSQTDRVDLGTLRGYYNQSEDGSHTIQIMYGCDVGSDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWETAHEAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1A32_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-36 A3601 ALPHA CHAIN PRECURSOR
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQKME
PRAPWIEQEGPEYWDQETRNMKAHSQTDRANLGTLRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQD
AYDGKDYIALNEDLRSWTAADMAAQITKRKWEAVHAAEQRRVYLEGTCVEWLRRYLENGKETLQRTDPPK
THMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASS
DSAQGSDVSLTACKV

>1A33_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-43 A4301 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDLQTRNVKAHSQTDRANLGTLRGYYNQSEDGSHTIQRMYGCDVGPDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWETAHEAEQWRAYLEGRCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1A34_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-66(A-10) A6601 ALPHA CHAIN PRECURSOR
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDRNTRNVKAQSQTDRVDLGTLRGYYNQSEDGSHTIQRMYGCDVGPDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWETAHEAEQWRAYLEGRCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1A35_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-66(A-10) A6602 ALPHA CHAIN PRECURSOR (AW67)
MAVMAPRTLVLLLSGALALTQTWAGSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDRNTRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQRMYGCDVGPDGRFLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWETAHEAEQWRAYLEGECVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVIAGAVVAAVMWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1A36_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-68(A-28) A6801 ALPHA CHAIN (AW68.1) (FRAGMENT)
GSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDRNTRNVKAQ
SQTDRVDLGTLRGYYNQSEAGSHTIQMMYGCDVGSDGRFLRGYRQDAYDGKDYIALKEDLRSWTAADMAA
QTTKHKWEAAHVAEQWRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYP
AEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWVAVVVPSGQEQRYTCHVQHEGLPKPLTLRW

>1A38_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-69(A-28) A6901 ALPHA CHAIN (FRAGMENT)
SHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDRNTRNVKAQS
QTDRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDGKDYIALKEDLRSWTAADMAAQ
TTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYPA
EITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRW

>1A39_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, AW-74(AW-19) A7401 ALPHA CHAIN PRECURSOR
MAVMAPRTLLLLLLGALALTQTRAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRME
PRAPWIEQEGPEYWDQETRNVKAHSQTDRVDLGTLRGYYNQSEAGSHTIQMMYGCDVGPDGRLLRGYQQD
AYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPK
THMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQR
YTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAMFAGAVVAAVRWRRKSSDRKGGSYSQAASS
DSAQGSDMSLTACKV

>1AXX_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-10 ALPHA CHAIN (FRAGMENT)
VKAQSQTHRVDLGTLRGYYNQSEAVSHTVQRMYGCDVGSDGRFLRGYHQVAYDGKDYIALKEDLRSWTAA
DMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWAL
SFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEP
SSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYSQAASSDSAQGSDVSLTACKV

>1B01_GORGO CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-B0101 ALPHA CHAIN PRECURSOR
MRVTAPRTLLLLLSAALALTETWAGSHSMRYFDTAVSRPGRGEPRFITVGYVDDTQFVRFDSDAASPRME
PRAPWIEQEGPEYWDRETQTSKAQAQTDRENLRIALRYYNQSEAGSHTIQRMFGCDVGPDGRLLRGYSQS
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGTCVEWLRRYLENGRETLQRADTPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEER
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVTAVICRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B01_PANTR CHLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-1 ALPHA CHAIN PRECURSOR (FRAGMENT)
APRTVLLLLSAALALTETWAGSHSMRYFYTSVSRPGRGEPRFITVGYVDDTQFVRFDSDAASPRMEPRAP
WIEQEGPEYWDRETRNMKASAQTDRENLRIALRYYNQSEAGSHTWQTMYGCDMGPDGRLLRGYGQYAYDG
KDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQRRAYLEGTCVEWLRRYLENGKETLQRADPPKTHVT
HHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPEGDRTFQKWAAVVVPSGEEQRYTCH
VQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLVVTVAVVAVVAAVMCRRKSSGGKGGSYSQAASSDSA
QGSDVSLTA

>1B01_SAGOE CLASS I HISTOCOMPATIBILITY ANTIGEN, B ALPHA CHAIN PRECURSOR
MTVMAPRTLLLLLSGALVLTETWAGSHSMRYFSTAVSRPGREEPRYIEVGYVDDTQFVRFDSDAASPRME
PRAQWVEKEGREYWEEETQRAKAFAQTFRVNLQTALGYYNQSEAGSHTIQMMSGCDLGPDGRLLRGYDQH
AYDGKDYISLNEDLRSWTAADVAAQITQRKWEAANEAERTRAYLEGTCVEWLHRYLENGKETLQRAEPPK
THVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDMELVETRPTGNGTFQKWAAVVVLSGEEHR
YTCHVQHEGLPEPLTLRWEPPSQPTIPIMGIVAILAILGAVVTGAVVTAVMWRKKSSDKKGGSYSQAARS
DSAQGSDVSLTACKV

>1B02_GORGO CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-B0102 ALPHA CHAIN PRECURSOR
MRVTAPRTLLLLLSAALALTETWAGSHSMRYFDTAVSRPGRGEPRFITVGYVDDTQFVRFDSDAASPRME
PRAPWIEQEGPEYWDRETQTSKAQAQTDRENLRIALRYYNQSEAGSHTFQRMFGCDVGPDGRLLRGYSQS
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGTCVEWLRRYLENGRETLQRADTPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEER
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVTAVICRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-7 B0702 ALPHA CHAIN PRECURSOR (B7.2)
MLVMAPRTVLLLLSAALALTETWAGSHSMRYFYTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREE
PRAPWIEQEGPEYWDRNTQIYKAQAQTDRESLRNLRGYYNQSEAGSHTLQSMYGCDVGPDGRLLRGHDQY
AYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGECVEWLRRYLENGKDKLERADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACS
DSAQGSDVSLTA

>1B02_PANTR CHLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-2 ALPHA CHAIN PRECURSOR
MQVTAPRTVLLLLSAALALTETWAGSHSMKYFYTAVSRPGRGEPRFISVGYVDDTQFVWFDSDAASPREE
PRAPWIEQEGPEYWDRETQISKTNAQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDMGPDGRLLRGYEQY
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARWAEQLRAYLEGTCVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B03_GORGO CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-B0103 ALPHA CHAIN PRECURSOR
MRVTAPRTLLLLLSAALALTETWAGSHSMRYFDTAVSRPGRGEPRFITVGYVDDTQFVRFDSDAASPRME
PRAPWIEQEGPEYWDRETQTSKAQAQTDRENLRIALRYYNQSEAGSHTIQWMYGCDMGPDGRLLRGYSQS
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGTCVEWLRRYLENGRETLQRADTPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEER
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVTAVICRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B04_GORGO CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-B0201 ALPHA CHAIN PRECURSOR
MQVTAPRTLLLLLSAALALTETWAGSHSMRYFHTAMSRPGRGEPRFITVGYVDDTQFVWFDSDAASPRKE
PRTPWIEQEGPEYWDRETQISKTNTQTYRVGLGTLRGYYNQSEDGSHTIQRMYGCDMGPDGRLLRGYSQL
AYDGKDYLALNEDLSSWTAADTAAQITQRKWEAARAAEQERAYLEGLCVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCRVQHEGLPEPLTLRWEPSSQSTIPIVGIVAGLAVLVVTVAVVAVVAAVMCRRKSSGGKGGSYSQAAS
SDSAQGSDVSLTA

>1B04_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-8 B0801 ALPHA CHAIN PRECURSOR
MLVMAPRTVLLLLSAALALTETWAGSHSMRYFDTAMSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREE
PRAPWIEQEGPEYWDRNTQIFKTNTQTDRESLRNLRGYYNQSEAGSHTLQSMYGCDVGPDGRLLRGHNQY
AYDGKDYIALNEDLRSWTAADTAAQITQRKWEAARVAEQDRAYLEGTCVEWLRRYLENGKDTLERADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACS
DSAQGSDVSLTA

>1B05_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-13 B1301 ALPHA CHAIN PRECURSOR (B13.1)
MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFITVGYVDDTQFVRFDSDATSPRMA
PRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHTWQTMYGCDLGPDGRLLRGHNQL
AYDGKDYIALNEDLSSWTAADTAAQITQLKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACS
DSAQGSDVSLTA

>1B07_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-14 B1401 ALPHA CHAIN PRECURSOR
MLVMAPRTVLLLLSAALALTETWAGSHSMRYFYTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREE
PRAPWIEQEGPEYWDRNTQICKTNTQTDRESLRNLRGYYNQSEAGSHTLQWMYGCDVGPDGRLLRGYNQF
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGTCVEWLRRHLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B08_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, BW-65(B-14) B1402 ALPHA CHAIN PRECURSOR
MLVMAPRTVLLLLSAALALTETWAGSHSMRYFYTAVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREE
PRAPWIEQEGPEYWDRNTQICKTNTQTDRESLRNLRGYYNQSEAGSHTLQWMYGCDVGPDGRLLRGYNQF
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGTCVEWLRRHLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B10_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, BW-75(B-15) B1502 ALPHA CHAIN PRECURSOR
MRVTAPRTVLLLLSGALALTETWAGSHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRMA
PRAPWIEQEGPEYWDRNTQISKTNTQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQS
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, BW-72(BW-70) B1503 ALPHA CHAIN PRECURSOR
MRVTAPRTVLLLLSGALALTETWAGSHSMRYFYTAMSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREE
PRAPWIEQEGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQS
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B12_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-62 B1504 ALPHA CHAIN PRECURSOR (FRAGMENT)
VLLLLSGALALTETWAGSHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRMAPRAPWIEQ
EGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHTWQTMYGCDVGPDGRLLRGHDQSAYDGKDYI
ALNEDLSSWTAADTAAQITQRKWEAAREAEQWRAYLEGLCVEWLRRYLENGKETLQRADPPKTHVTHHPI
SDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHE
GLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASSDSAQGSDV
SLTA

>1B13_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-18 B1801 ALPHA CHAIN PRECURSOR
MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFHTSVSRPGRGEPRFISVGYVDGTQFVRFDSDAASPRTE
PRAPWIEQEGPEYWDRNTQISKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQS
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRHLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA

>1B14_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-27 ALPHA CHAIN PRECURSOR
MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFHTSVSRPGRGEPRFITVGYVDDTLFVRFDSDAASPREE
PRAPWIEQEGPEYWDRETQICKAKAQTDREDLRTLLRYYNQSEAGSHTLQNMYGCDVGPDGRLLRGYHQD
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAASA
TVPRALMCLSQ

>1B15_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-27 B2702 ALPHA CHAIN PRECURSOR (B-27K) (B27.2)
MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFHTSVSRPGRGEPRFITVGYVDDTLFVRFDSDAASPREE
PRAPWIEQEGPEYWDRETQICKAKAQTDRENLRIALRYYNQSEAGSHTLQNMYGCDVGPDGRLLRGYHQD
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACS
DSAQGSDVSLTA

>1B16_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-27 B2703 ALPHA CHAIN PRECURSOR (B-27D)
MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFHTSVSRPGRGEPRFITVGYVDDTLFVRFDSDAASPREE
PRAPWIEQEGPEHWDRETQICKAKAQTDREDLRTLLRYYNQSEAGSHTLQNMYGCDVGPDGRLLRGYHQD
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACS
DSAQGSDVSLTA

>1B18_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-27 B2705 ALPHA CHAIN PRECURSOR (B-27W) (B27.1)
MRVTAPRTLLLLLWGAVALTETWAGSHSMRYFHTSVSRPGRGEPRFITVGYVDDTLFVRFDSDAASPREE
PRAPWIEQEGPEYWDRETQICKAKAQTDREDLRTLLRYYNQSEAGSHTLQNMYGCDVGPDGRLLRGYHQD
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRADPPK
THVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACS
DSAQGSDVSLTA

>1B20_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-27 B2707 ALPHA CHAIN (B27-HS)
GSHSMRYFHTSVSRPGRGEPRFITVGYVDDTLFVRFDSDAASPREEPRAPWIEQEGPEYWDRETQICKAK
AQTDREDLRTLLRYYNQSEAGSHTLQSMYGCDVGPDGRLLRGHNQYAYDGKDYIALNEDLRSWTAADTAA
QITQRKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRADPPKTHVTHHPISDHEATLRCWALGFYP
AEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQS
TVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACSDSAQGSDVSLTA

>1B21_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35 B3501 ALPHA CHAIN PRECURSOR
MRVTAPRTVLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTE
PRAPWIEQEGPEYWDRNTQIFKTNTQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHDQS
AYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLRRYLENGKETLQRADPPK
THVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQR
YTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASS
DSAQGSDVSLTA